One of the world’s largest pharmaceutical companies required a comparative effectiveness review of premixed insulin analogs compared to basal or basal-bolus regimens (utilizing glargine and/or glulisine) for individuals with type 2 diabetes
We understand your hurdles, your objectives, and your limitations, which is why we focus on providing you with prompt, compliant, and accurate recommendations and solutions tailored to meet your business needs.
© 2009 The Aequitas Group, Inc. All Rights Reserved.